IHS Chemical Week

Markets :: Basic Chemicals :: Petrochemicals :: Caprolactam

DSM's fourth-quarter net profit down 75% despite higher sales

5:01 AM MST | February 20, 2013 | Francinia Protti-Alvarez

DSM's fourth-quarter 2012 net profit fell by 75%, to €21 million ($28 million), compared with the €85 million reported in the fourth quarter a year earlier, the company said today. Ebitda was also down 17%,  to €243 million. Net sales went up marginally from €2.23 billion during the last quarter of 2011, to €2.27 billion during the same period last year—about a 2% increase. In DSM's life sciences division, the nutrition business contributed just over 40% of total sales, reporting €923 million, compared with €865...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa